Analyst Lisa De Neve of Morgan Stanley maintained a Hold rating on Givaudan SA, retaining the price target of CHF2,875.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lisa De Neve has given his Hold rating due to a combination of factors, balancing near‑term strength with emerging headwinds. Givaudan’s first‑quarter results exceeded expectations, driven in particular by strong momentum in Fine Fragrances and Consumer Products, but this was tempered by softness in Latin America and certain Taste & Wellbeing regions, where weaker demand and adverse FX-related pricing weighed on performance.
At the same time, the company faces a less favourable cost backdrop, with rising raw material and logistics expenses and only gradual pass‑through of price increases to customers. Management is focused on implementing these price hikes to offset inflation, while acknowledging that some markets remain difficult, which could constrain volume trends and earnings visibility. Together, these elements suggest limited near‑term upside versus the current valuation, supporting a neutral, or Hold, stance on the shares.
In another report released today, Barclays also maintained a Hold rating on the stock with a CHF3,050.00 price target.
